LUC00154I2 - - Google Patents

Download PDF

Info

Publication number
LUC00154I2
LUC00154I2 LU00154C LUC00154C LUC00154I2 LU C00154 I2 LUC00154 I2 LU C00154I2 LU 00154 C LU00154 C LU 00154C LU C00154 C LUC00154 C LU C00154C LU C00154 I2 LUC00154 I2 LU C00154I2
Authority
LU
Luxembourg
Application number
LU00154C
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43383475&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00154(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of LUC00154I1 publication Critical patent/LUC00154I1/fr
Publication of LUC00154I2 publication Critical patent/LUC00154I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU00154C 2009-10-27 2020-05-19 LUC00154I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25515909P 2009-10-27 2009-10-27
PCT/FI2010/000065 WO2011051540A1 (fr) 2009-10-27 2010-10-27 Composés modulateurs de récepteurs des androgènes

Publications (2)

Publication Number Publication Date
LUC00154I1 LUC00154I1 (fr) 2020-05-19
LUC00154I2 true LUC00154I2 (fr) 2021-02-17

Family

ID=43383475

Family Applications (1)

Application Number Title Priority Date Filing Date
LU00154C LUC00154I2 (fr) 2009-10-27 2020-05-19

Country Status (37)

Country Link
US (5) US8975254B2 (fr)
EP (5) EP3369732B1 (fr)
JP (1) JP5763083B2 (fr)
KR (2) KR101654529B1 (fr)
CN (2) CN102596910B (fr)
AR (1) AR078793A1 (fr)
AU (1) AU2010311299C1 (fr)
BR (1) BR112012008823B8 (fr)
CA (1) CA2777896C (fr)
CL (1) CL2012000772A1 (fr)
CO (1) CO6531494A2 (fr)
CY (2) CY2020010I2 (fr)
DK (4) DK3056485T3 (fr)
EA (1) EA021170B1 (fr)
ES (4) ES2877248T3 (fr)
FI (1) FI3885340T3 (fr)
GE (1) GEP20166472B (fr)
HR (4) HRP20241681T1 (fr)
HU (4) HUE039390T2 (fr)
IL (2) IL218586A (fr)
LT (4) LT3369732T (fr)
LU (1) LUC00154I2 (fr)
MX (1) MX2012004867A (fr)
MY (1) MY159924A (fr)
NL (1) NL301041I2 (fr)
NO (1) NO2020018I1 (fr)
NZ (1) NZ598747A (fr)
PE (1) PE20121058A1 (fr)
PH (1) PH12012500782A1 (fr)
PL (4) PL3369732T3 (fr)
PT (4) PT3885340T (fr)
RS (4) RS57592B1 (fr)
SI (4) SI3369732T1 (fr)
SM (3) SMT202400534T1 (fr)
UA (1) UA109535C2 (fr)
WO (1) WO2011051540A1 (fr)
ZA (1) ZA201202655B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2603032T3 (es) * 2010-07-15 2017-02-23 Bayer Intellectual Property Gmbh Compuestos de 3-piridil-heteroarilcarboxamida como pesticidas
US8921378B2 (en) * 2011-04-21 2014-12-30 Orion Corporation Androgen receptor modulating carboxamides
EP2574607A1 (fr) * 2011-09-06 2013-04-03 F. Hoffmann-La Roche AG Modulateurs PDE10
KR102057357B1 (ko) * 2012-03-15 2019-12-18 시그날 파마소티칼 엘엘씨 Tor 키나제 억제제를 사용한 암의 치료
TW201343644A (zh) * 2012-03-23 2013-11-01 Nihon Nohyaku Co Ltd 噻唑羧醯胺衍生物及其使用方法
WO2013187466A1 (fr) 2012-06-15 2013-12-19 大正製薬株式会社 Dérivé cyclique hétéroaromatique alkylé à chaîne ramifiée
HK1211589A1 (zh) 2012-08-23 2016-05-27 Alios Biopharma, Inc. 用於治疗副粘病毒病毒性感染的化合物
CN102952095A (zh) * 2012-10-19 2013-03-06 盛世泰科生物医药技术(苏州)有限公司 一种2-羧酸乙酯-5-溴甲基噻唑的合成方法
HK1225716A1 (zh) 2013-08-21 2017-09-15 Alios Biopharma, Inc. 抗病毒化合物
WO2015172196A1 (fr) * 2014-05-13 2015-11-19 Monash University Composés hétérocycliques et leur utilisation
MX390189B (es) 2015-01-20 2025-03-20 Arvinas Operations Inc COMPUESTOS Y METODOS PARA LA DEGRADACION DIRIGIDA DE RECEPTOR DE ANDROGENOs.
US12312316B2 (en) 2015-01-20 2025-05-27 Arvinas Operations, Inc. Compounds and methods for the targeted degradation of androgen receptor
HUE058986T2 (hu) 2015-01-30 2022-09-28 Orion Corp Egy karboxamid-származék és annak diasztereomerei stabil kristályformában
MA41614A (fr) * 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
MX378231B (es) * 2015-04-09 2025-03-10 Orion Corp Proceso para la preparación de antagonistas del receptor andrógeno e intermediarios de los mismos.
WO2016187324A1 (fr) * 2015-05-18 2016-11-24 Td2, Inc. Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinases
AU2016368257C1 (en) * 2015-12-07 2019-12-05 Suzhou Sinovent Pharmaceuticals Co., Ltd. Five-membered heterocyclic amides wnt pathway inhibitor
CN107286094A (zh) * 2016-04-12 2017-10-24 常州爱诺新睿医药技术有限公司 一种bay-1841788与药用辅料的固体分散体及其制备方法
CN109641851B (zh) * 2016-08-26 2022-09-02 拜耳消费者护理股份有限公司 一种雄激素受体拮抗剂药物的晶型及其制备方法和用途
IL318681A (en) 2016-10-11 2025-03-01 Arvinas Operations Inc Compounds and methods for targeted reduction of androgen receptor
AU2018229817B2 (en) 2017-03-07 2021-09-30 Orion Corporation Manufacture of a crystalline pharmaceutical product
CA3068324A1 (fr) 2017-06-28 2019-01-03 Bayer Consumer Care Ag Combinaison d'un inhibiteur de pi3k et d'un antagoniste du recepteur des androgenes
US11236073B2 (en) 2017-08-09 2022-02-01 Hangzhou Solipharma Co., Ltd. ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof
CN107602471B (zh) * 2017-09-22 2021-04-27 成都恒汇化成医药科技有限公司 一种达罗鲁胺的晶型制备方法
WO2019166385A1 (fr) 2018-02-27 2019-09-06 Sandoz Ag Forme cristalline ii de darolutamide
US20220062281A1 (en) * 2018-08-13 2022-03-03 National Centre For Biological Sciences-Tifr Inhibitors to target hiv-1 nef-cd80/cd86 interactions for therapeutic intervention
WO2020095183A1 (fr) 2018-11-05 2020-05-14 Pfizer Inc. Combinaison pour le traitement du cancer
CN113365623B (zh) 2019-01-30 2025-06-24 阿拉贡药品公司 用于治疗转移性去势敏感性前列腺癌的抗雄激素
US11802113B2 (en) * 2019-02-27 2023-10-31 Shenzhen Targetrx, Inc. Substituted pyrazole compounds, compositions containing same, and use thereof
AU2020300043B2 (en) 2019-07-02 2025-03-20 Orion Corporation Pharmaceutical composition of darolutamide
CN110590668A (zh) * 2019-07-17 2019-12-20 江苏君若医药有限公司 N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法
US20210038578A1 (en) 2019-08-08 2021-02-11 Laekna Limited Method of treating cancer
CN111116476A (zh) * 2019-12-27 2020-05-08 武汉九州钰民医药科技有限公司 制备抗肿瘤药物多拉米胺的方法
TW202208345A (zh) 2020-05-09 2022-03-01 美商亞文納營運公司 雙官能性化合物的製造方法、該雙官能性化合物的超純形式、及含彼之劑型
KR20230009958A (ko) 2020-05-11 2023-01-17 오리온 코포레이션 안드로겐 수용체 길항제 및 이의 중간체의 제조 방법
JP2023537595A (ja) 2020-08-13 2023-09-04 ファイザー・インク 併用治療
CN111978534B (zh) * 2020-09-07 2022-05-31 陕西师范大学 一种含苯并咪唑液晶基元的侧链型液晶离聚物及其制备方法
MX2023011294A (es) 2021-03-24 2023-10-05 Pfizer Combinacion de talazoparib y un antiandrogeno para el tratamiento del cancer de prostata sensible a la castracion metastasico mutado en el gen ddr.
WO2023012711A1 (fr) * 2021-08-04 2023-02-09 주식회사 엘지화학 Nouveau composé et dispositif électroluminescent organique le comprenant
CN113527208A (zh) * 2021-08-31 2021-10-22 江西金丰药业有限公司 一步法制备2-氯-4-（1h-吡唑-3-基）苯甲腈的方法
CN113861115A (zh) * 2021-09-10 2021-12-31 浙江师范大学 一种吡唑酰胺类衍生物及合成方法和应用
CN118974018A (zh) 2022-02-28 2024-11-15 奎米卡新特缇卡股份有限公司 达罗他胺的晶型
JP7805983B2 (ja) 2022-03-22 2026-01-26 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン
IL316016A (en) 2022-04-07 2024-11-01 Astrazeneca Ab Combined treatment for cancer
TWI883565B (zh) 2022-10-02 2025-05-11 美商輝瑞大藥廠 用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
WO2024121163A1 (fr) 2022-12-06 2024-06-13 Cancer Research Technology Limited Combinaison de 10d1f et d'un inhibiteur des androgènes pour le traitement et la prévention de cancers
TW202425976A (zh) 2022-12-17 2024-07-01 美商輝瑞大藥廠 用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
TW202521513A (zh) 2023-08-17 2025-06-01 芬蘭商奧利安公司 雄性素受體拮抗劑及其中間物之製備方法
CN117776973A (zh) * 2023-09-20 2024-03-29 山东特珐曼药业有限公司 一种4-甲酰基-3-甲氧基苯甲腈的制备方法
US12496301B2 (en) 2023-12-08 2025-12-16 Arvinas Operations, Inc. Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy
WO2025146444A1 (fr) 2024-01-03 2025-07-10 Bayer Aktiengesellschaft Darolutamide en combinaison avec des inhibiteurs de braf et de mek pour le traitement d'un mélanome
WO2025229051A1 (fr) 2024-05-03 2025-11-06 F. Hoffmann-La Roche Ag Utilisation d'inhibiteurs d'atr en combinaison avec un agent anti-androgène
CN121226255A (zh) * 2025-09-25 2025-12-30 安徽益普克医药科技发展有限公司 一种达罗他胺衍生物及其制备方法与用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
FR2656609B1 (fr) 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
CZ244394A3 (en) 1993-10-08 1995-06-14 Shell Int Research Herbicidal 1,2,4-oxadiazolecarboxylic acids amides, esters or halides
FR2741342B1 (fr) 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
US6673799B1 (en) 1998-09-22 2004-01-06 Yamanouchi Pharmaceutical Co. Ltd. Cyanophenyl derivative
JP2005508978A (ja) 2001-11-02 2005-04-07 ファイザー・プロダクツ・インク Ｐｄｅ９阻害薬によるインスリン抵抗性症候群及び２型糖尿病の治療
MXPA04006184A (es) * 2001-12-28 2004-12-06 Bayer Pharmaceuticals Corp Compuestos derivados de 1h-pirazolilo, para el uso en enfermedades asociadas con el receptor 5-ht2c.
WO2003057674A1 (fr) * 2001-12-28 2003-07-17 Bayer Pharmaceuticals Corporation Composes derives de 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyle destines au traitement des maladies associees au recepteur 5-ht2c
US20050101657A1 (en) 2001-12-28 2005-05-12 Takeda Chemical Industries Ltd. Androgen receptor antagonists
US20040180889A1 (en) 2002-03-01 2004-09-16 Pintex Pharmaceuticals, Inc. Pin1-modulating compounds and methods of use thereof
AR040149A1 (es) * 2002-06-07 2005-03-16 Novartis Ag Compuestos de aminoacetonitrilo, un proceso para su preparacion, composicion, y uso del compuesto
MXPA05001334A (es) * 2002-08-02 2005-09-08 Argenta Discovery Ltd Acidos tienil-hidroxamicos sustituidos como inhibidores de la desacetilasa de histona.
DE10322108B4 (de) 2003-05-09 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
JP4664814B2 (ja) 2003-06-12 2011-04-06 中外製薬株式会社 イミダゾリジン誘導体
WO2005030704A1 (fr) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibiteurs d'histone deacetylase
AU2005280908A1 (en) 2004-09-09 2006-03-16 Chugai Seiyaku Kabushiki Kaisha Novel imidazolidine derivative and use thereof
JP2008007405A (ja) * 2004-12-07 2008-01-17 Takeda Chem Ind Ltd カルボキサミド誘導体
EP1710237A1 (fr) * 2005-04-08 2006-10-11 Bayer CropScience S.A. Dérivés nouveaux du hétérocyclylethylbenzamide
EP3106162A1 (fr) 2005-05-13 2016-12-21 The Regents of the University of California Composes diarylhydantoines en tant qu'antagonistes du recepteur d'androgene pour le traitement du cancer
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
WO2007005887A2 (fr) * 2005-07-01 2007-01-11 Ligand Pharmaceuticals Incorporated Composes de modulation des recepteur des androgenes et methodes associees
GB0518237D0 (en) * 2005-09-07 2005-10-19 Angeletti P Ist Richerche Bio Therapeutic compounds
EP2298770A1 (fr) * 2005-11-03 2011-03-23 ChemBridge Corporation Composés hétérocycliques en tant que modulateurs de TrkA
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
JP5205274B2 (ja) 2006-11-22 2013-06-05 日本農薬株式会社 新規なピラゾール誘導体、有害生物防除剤及びその使用方法
WO2008124000A2 (fr) 2007-04-02 2008-10-16 Ligand Pharmaceuticals Incorporated Dérivés de thiazole utilisés comme composés modulateurs de récepteurs d'androgènes
AU2008273017C1 (en) * 2007-06-29 2014-02-13 Millennium Pharmaceuticals, Inc. Heterocyclic compounds useful as Raf kinase inhibitors
US20100227846A1 (en) 2007-08-30 2010-09-09 Takeda Pharmaceutical Company Limited Substituted pyrazole derivative
CA2966280A1 (fr) 2007-10-26 2009-04-30 The Regents Of The University Of California Composes de diaryl-hydantoine
TW200944506A (en) 2008-03-26 2009-11-01 Takeda Pharmaceutical Substituted pyrazole derivatives and use thereof
EP2307378A1 (fr) 2008-06-18 2011-04-13 Pfizer Limited Dérivés de nicotinamide

Also Published As

Publication number Publication date
EP3885340A1 (fr) 2021-09-29
RS66289B1 (sr) 2025-01-31
JP5763083B2 (ja) 2015-08-12
HUE069657T2 (hu) 2025-04-28
PL3056485T3 (pl) 2018-12-31
CA2777896C (fr) 2017-05-23
GEP20166472B (en) 2016-05-10
US20200299307A1 (en) 2020-09-24
PT2493858E (pt) 2014-09-03
PT3885340T (pt) 2024-12-16
WO2011051540A8 (fr) 2012-05-24
ZA201202655B (en) 2012-12-27
PL3885340T3 (pl) 2025-03-24
PT3369732T (pt) 2021-07-06
BR112012008823B8 (pt) 2021-05-25
EP2493858B1 (fr) 2014-07-02
EA201270597A1 (ru) 2012-10-30
US20170260206A1 (en) 2017-09-14
RS62123B1 (sr) 2021-08-31
US10118933B2 (en) 2018-11-06
ES2486263T3 (es) 2014-08-18
NO2020018I1 (no) 2020-06-17
EA021170B1 (ru) 2015-04-30
SI2493858T1 (sl) 2014-10-30
AU2010311299C1 (en) 2023-02-02
BR112012008823A2 (pt) 2019-02-19
PL2493858T3 (pl) 2015-01-30
US11046713B2 (en) 2021-06-29
BR112012008823B1 (pt) 2021-01-12
UA109535C2 (uk) 2015-09-10
AU2010311299B2 (en) 2014-07-17
FI3885340T3 (fi) 2025-02-03
EP3369732A1 (fr) 2018-09-05
EP3885340B1 (fr) 2024-11-27
CN105061313B (zh) 2017-07-18
RS53469B (sr) 2014-12-31
KR101654529B1 (ko) 2016-09-06
SMT202400534T1 (it) 2025-01-14
SMT201400138B (it) 2014-11-10
PL3369732T3 (pl) 2021-12-06
PT3056485T (pt) 2018-07-31
HUS2000012I1 (hu) 2020-07-28
KR101670299B1 (ko) 2016-10-28
LTPA2020514I1 (lt) 2020-07-27
AR078793A1 (es) 2011-12-07
WO2011051540A9 (fr) 2012-06-21
CY2020010I1 (el) 2020-11-25
SI3885340T1 (sl) 2025-02-28
CY1124429T1 (el) 2022-07-22
NL301041I2 (nl) 2020-09-14
LT3056485T (lt) 2018-07-25
LT3369732T (lt) 2021-06-25
MY159924A (en) 2017-02-15
SI3369732T1 (sl) 2021-08-31
US20190100536A1 (en) 2019-04-04
CL2012000772A1 (es) 2012-08-24
SI3056485T1 (en) 2018-08-31
MX2012004867A (es) 2012-06-08
DK3056485T3 (en) 2018-07-30
ES2877248T3 (es) 2021-11-16
US9657003B2 (en) 2017-05-23
RS57592B1 (sr) 2018-11-30
EP3056485A1 (fr) 2016-08-17
CN105061313A (zh) 2015-11-18
AU2010311299A1 (en) 2012-04-12
DK3369732T3 (da) 2021-07-26
SMT202100480T1 (it) 2021-09-14
CN102596910B (zh) 2015-11-25
ES2997997T3 (en) 2025-02-18
NZ598747A (en) 2013-06-28
IL238044A (en) 2016-07-31
IL218586A (en) 2015-10-29
KR20120102057A (ko) 2012-09-17
WO2011051540A1 (fr) 2011-05-05
EP3056485B1 (fr) 2018-05-09
KR20160105927A (ko) 2016-09-07
US20120225867A1 (en) 2012-09-06
PH12012500782A1 (en) 2016-05-27
CO6531494A2 (es) 2012-09-28
HK1173442A1 (zh) 2013-05-16
LUC00154I1 (fr) 2020-05-19
US8975254B2 (en) 2015-03-10
DK2493858T3 (da) 2014-09-08
PE20121058A1 (es) 2012-08-18
HRP20181229T1 (hr) 2018-10-05
HUE039390T2 (hu) 2018-12-28
HRP20211180T1 (hr) 2021-10-15
ES2678073T3 (es) 2018-08-08
EP3369732B1 (fr) 2021-05-26
CA2777896A1 (fr) 2011-05-05
HRP20241681T1 (hr) 2025-02-28
US10711013B2 (en) 2020-07-14
LT3885340T (lt) 2024-12-27
LTC2493858I2 (lt) 2022-03-25
CY2020010I2 (el) 2020-11-25
DK3885340T3 (da) 2025-01-06
CN102596910A (zh) 2012-07-18
HRP20140919T1 (hr) 2014-11-21
EP2493858A1 (fr) 2012-09-05
EP2754656A1 (fr) 2014-07-16
US20150203479A1 (en) 2015-07-23
IL218586A0 (en) 2012-05-31
HUE055528T2 (hu) 2021-12-28
AU2010311299A8 (en) 2012-06-14
JP2013508447A (ja) 2013-03-07

Similar Documents

Publication Publication Date Title
BRPI0925311A2 (fr)
BRPI0924307A2 (fr)
BR112012008267A2 (fr)
BR112012012396A2 (fr)
BR122017024704A2 (fr)
BRPI0924534A2 (fr)
BR112012012080A2 (fr)
BR112012009446A2 (fr)
BR112012009797A2 (fr)
BR112012009703A2 (fr)
BRPI1005795A2 (fr)
BR112012010357A2 (fr)
BR112012007656A2 (fr)
BRPI1004942A2 (fr)
BR122019005883A2 (fr)
BR112012014856A2 (fr)
BR112012000159A2 (fr)
BR112012007654A2 (fr)
BR112012005951A2 (fr)
BR112012007671A2 (fr)
BR112012009404A2 (fr)
BRPI0924617A2 (fr)
BR122017013721A2 (fr)
BR112012016234A2 (fr)
BR112012000689A2 (fr)